What does Fate Therapeutics, Inc. do?
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical…
What is Fate Therapeutics, Inc.'s P/E and P/B ratio?
Fate Therapeutics, Inc. has a P/E ratio of -2.0 and a P/B ratio of 1.63.
What is Fate Therapeutics, Inc.'s debt-to-equity ratio?
Fate Therapeutics, Inc. has a debt-to-equity ratio of 0.49.
How much does Fate Therapeutics, Inc. owe compared with what it owns?
Fate Therapeutics, Inc. owes $0.41 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Fate Therapeutics, Inc.'s Positivity rank?
Fate Therapeutics, Inc. is ranked #4,406 of 6,774 companies globally and #2,193 of 4,000 in United States on PositoAI, with a Positivity Score of 19,496.
Does Fate Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Fate Therapeutics, Inc..
Where can I read the latest news about Fate Therapeutics, Inc.?
Recent headlines about Fate Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Fate Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Fate Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.